Anthem Blue Cross and Blue Shield Nevada policy
MED.00129 Gene Therapy for Spinal Muscular Atrophy
MED.00129 Gene Therapy for Spinal Muscular Atrophy is a public Anthem Blue Cross and Blue Shield Nevada policy (policy MED.00129). It lists 2 CPT or HCPCS codes, 1 of them on the Anthem Blue Cross and Blue Shield Nevada prior authorization list. Not a coverage decision; the payer's own document governs.
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- MED.00129
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross and Blue Shield Nevada prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross and Blue Shield Nevada policies |
|---|---|---|---|
| J3399 | On the list | Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes | Policies naming J3399 |
| J3405 | Not listed | Policies naming J3405 |
All Anthem Blue Cross and Blue Shield Nevada policies · Anthem Blue Cross and Blue Shield Nevada prior authorization CPT list